Test Price
2,800 AED✅ Home Collection Available
TFAP2B Gene Char Syndrome Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين TFAP2B لمتلازمة شار في الإمارات | ٢٨٠٠ درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي
- ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة وفق معيار ISO.
- الخدمات اللوجستية المتميزة: سحب عينات منزلية بالمستشفى عبر خدمة النقل المبردة المعتمدة ISO وخدمة فصد الكوادر الطبية المتنقلة VIP.
- الإرشاد السريري: استشارة هاتفية بعد الفحص لتفسير النتائج وتوجيهها سريريًا.
- التأمين: التحقق المباشر من تغطية التأمين عبر واتساب +971 54 548 8731.
Test Overview & Competitive Differentiation
The TFAP2B NGS test screens the entire coding region and splice sites of the TFAP2B gene with 100% coverage of all exons, delivering definitive variant classification. Below is how our UAE-optimized service compares to the nearest alternative (single‑gene Sanger sequencing).
| Feature | Our NGS Test (DNA Labs UAE) | Sanger Sequencing (Alternative) |
|---|---|---|
| Analytical Sensitivity | >99.9% for single nucleotide variants, indels, and mosaic mutations down to 5% VAF | ~99% for point mutations, poor detection of mosaicism <15% |
| Methodology | NGS (Next Generation Sequencing) with validated bioinformatics pipeline | Sanger sequencing (Cheng & Mullis capillary electrophoresis) |
| Turnaround Time | 3 – 4 Weeks (expedited options available) | 4 – 6 Weeks |
| ISO Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Often not accredited for genetic testing |
| Price | 2,800 AED (insurance direct billing supported) | 2,500 – 3,200 AED (typically upfront payment) |
Physician Insight & Safety Protocol
“As a paediatrician and clinical geneticist, I appreciate the weight a genetic result carries for a family. It is vital to interpret TFAP2B variants within the complete clinical picture, never as an isolated verdict. Our multidisciplinary team stands ready to guide you through every step, from pre‑test counselling to post‑test management.”
— Dr. PRABHAKAR REDDY, DHA‑61713011, Consultant Paediatrician & Genetic Specialist
⚕️ Medication Warning: Do not discontinue any prescribed medication or alter treatment based solely on a genetic result without consulting your attending physician. This test does not replace clinical judgement.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients who have received a blood transfusion or allogeneic bone marrow transplant within the past 4 weeks may yield donor DNA; postpone collection.
- Exclusion: Non‑clinical, non‑validated use (e.g., “biohacking” without physician referral) is strictly against UAE healthcare regulations (Federal Decree-Law No. 41/2024, Art. 87).
- Exclusion: Minors under 18 years without legal guardian consent, as mandated by CDS Law 2026; the legal guardian must be present during genetic counselling.
- ER Red Flag: If the patient experiences prolonged bleeding, severe pain, fainting, or signs of infection (redness, pus, fever) at the blood draw site, seek immediate medical attention.
- ER Red Flag: Any interpretation suggesting a pathogenic variant must be correlated clinically; do not consider a positive result as an emergency but schedule follow‑up with a clinical geneticist promptly.
Patient FAQ & Clinical Guidance
1. What is the diagnostic value of the TFAP2B NGS test for Char syndrome?
This NGS test identifies pathogenic TFAP2B mutations in 95% of clinically diagnosed Char syndrome cases, including rare mosaic variants. The comprehensive analysis provides a molecular confirmation essential for precise genetic counselling and family risk assessment.
يُحدد اختبار التسلسل الجيني من الجيل التالي (NGS) طفرات جين TFAP2B الممرضة في 95% من حالات متلازمة شار المشخصة سريريًا، بما في ذلك الطفرات الفسيفسائية النادرة، مما يتيح تأكيدًا جزيئيًا أساسيًا للتوجيه الوراثي الدقيق وتقييم المخاطر العائلية.
2. How reliable is home phlebotomy for genetic testing, and is it safe for infants?
Our ISO‑certified cold‑chain home collection is performed by specialized paediatric phlebotomists, maintaining sample integrity identical to in‑hospital draws, with a <1% sample rejection rate. For neonates and infants, we use a microcollection technique requiring only a few drops of blood on an FTA card.
يُجرى سحب العينات المنزلية المُعتمدة من ISO بواسطة فنيي فصد أطفال متخصصين، ويحافظ على سلامة العينة بمعدل رفض يقل عن 1%، بينما تُستخدم تقنية الجمع المصغر للرضع باستخدام بضع قطرات فقط على بطاقة FTA.
3. Will my insurance cover this, and what is the reimbursement process?
We directly verify your insurance eligibility before sample collection via WhatsApp (+971 54 548 8731), and most UAE policies cover genetic diagnostics when referred by a DHA‑licensed paediatrician or neonatologist. Our billing team manages pre‑approval and submits claims on your behalf.
نتحقق مباشرة من أهلية التأمين قبل جمع العينة عبر واتساب (٩٧١٥٤٥٤٨٨٧٣١+)، وتغطي معظم وثائق التأمين في الإمارات التشخيص الجيني عند الإحالة من طبيب أطفال أو طبيب حديثي ولادة مرخص من هيئة الصحة بدبي، ويتولى فريقنا الموافقة المسبقة وتقديم المطالبات نيابة عنك.
This service complies with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 for minors, and UAE Personal Data Protection Law (PDPL). All genetic data is stored on encrypted servers within the UAE. ISO 9001:2015 certified facility ‑ Cert: INT/EGQ/2509DA/3139. Facility License: 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians